Knight Cancer signal achievements of 2021

In a year that was anything but normal, the OHSU Knight Cancer Institute’s people stepped up and continued to do great things. From basic research, to patient care, to impact in the community, the...

Seven at OHSU among world’s most influential scientists

Seven OHSU scientists are among the world's most highly cited, according to the consulting and data analysis firm Clarivate, which compiles an annual list of researchers who have demonstrated...

Jamming fat metabolism stops blood cancer cells

Targeted cancer therapies work by blocking specific, cancer-driving mutations. But in a new laboratory study, researchers show that cancers driven by several different mutations can all be stopped by...

‘Scissor’ opens view to single cells of cancer, other diseases

Cancerous tumors are composed of cells that may look the same but are in fact incredibly diverse. Mutations and changes in gene activity give rise to competing sub-populations of tumor cells with...

Targeting uniquely dangerous postpartum breast cancers

Breast cancers that emerge within five to ten years of pregnancy are more likely to become life-threatening. A new study finds that these postpartum breast tumors represent a unique subtype of cancer...

Clinical trial elevates new target for fighting cancers

Researchers have verified a much-needed new target for treating cancers that often become resistant to existing therapies and become deadly. In an early-phase clinical trial, the researchers tested...

Valuable recognition for OHSU’s molecular pathology fellowship

OHSU’s Molecular Genetic Pathology Fellowship has received a grant from NeoGenomics Laboratories that will support fellows for the 2021-22 and 2022-23 academic years in the Knight Cancer...